Top 8 Biotechnology companies in South Korea
This curated ranking covers the 8 largest biotechnology companies in South Korea, ordered by estimated audience size from Rascasse's anonymized search-behavior signals. AbbVie, Genentech and Gilead lead the list with a combined estimated audience of 36,762 people. Across all 8 entries the average audience size is 5,810, and the largest, AbbVie, reaches around 21,094 people in South Korea. Audience size is the estimated number of unique people in South Korea who actively engage with each biotechnology company, derived from search demand signals. Rankings reflect search-behavior signals collected across South Korea and are refreshed weekly.
Ranking
| Rank | Name | Audience size | Country share | Subtype | Category |
|---|---|---|---|---|---|
| 1 |  AbbVie |
21,094 | 1.0% | Biotechnology company | Health |
| 2 |  Genentech |
8,919 | 1.0% | Biotechnology company | Health |
| 3 |  Gilead |
6,749 | 0.6% | Biotechnology company | Health |
| 4 |  BionTech |
3,823 | 0.2% | Biotechnology company | Health |
| 5 |  Gilead Sciences |
2,725 | 0.4% | Biotechnology company | Health |
| 6 |  Tecan Group |
1,650 | 1.0% | Biotechnology company | Business & Career |
| 7 |  Bachem Holding |
988 | 0.3% | Biotechnology company | Business & Career |
| 8 |  CureVac |
537 | 0.2% | Biotechnology company | Health |
Frequently asked questions
How is this Top 8 list compiled?
Rascasse aggregates anonymized search-behavior signals across South Korea and ranks each biotechnology company by its estimated audience size. Only entries with at least 5 measured entities are listed.
How often is the list updated?
The ranking is refreshed weekly from the latest search-behavior data and re-published as a static page.
What is the largest biotechnology company in South Korea?
AbbVie currently leads with an estimated audience of 21,094 people in South Korea.
Methodology
Audience sizes are estimated from anonymized search-behavior signals across South Korea. Lists below 5 entries are not published. See methodology for full details.